Volt conducted independent tests from three wells which had lithium concentrations ranging between 79.1 mg/L to 91.3 mg/L.

Ozempic, a once-weekly glucagon-like peptide-1 (GLP-1) analogue, is currently approved in the EU in 0.5 mg and 1.0 mg doses for the treatment of type 2 diabetes in adults.